|
Drug Monitoring and Toxicology
Citations 121-130 of 565 total displayed.
|
Past content
(since Jan 1997):
|
- Editorials
Atherogenic Index of Plasma [Log(Triglycerides/HDL-Cholesterol)]: Theoretical and Practical Implications
- Milada Dobiásová
Clin. Chem. 2004; 50: 1113-1115.
[Extract]
[Full text]
[PDF]
- Lipids, Lipoproteins, and Cardiovascular Risk Factors
Pioglitazone Reduces Atherogenic Index of Plasma in Patients with Type 2 Diabetes
- Meng H. Tan, Don Johns, and N. Bradly Glazer
Clin. Chem. 2004; 50: 1184-1188.
[Abstract]
[Full text]
[PDF]
- Hematology
Denaturing-HPLC-Based Assay for Detection of ABL Mutations in Chronic Myeloid Leukemia Patients Resistant to Imatinib
- Simona Soverini, Giovanni Martinelli, Marilina Amabile, Angela Poerio, Michele Bianchini, Gianantonio Rosti, Fabrizio Pane, Giuseppe Saglio, and Michele Baccarani
Clin. Chem. 2004; 50: 1205-1213.
[Abstract]
[Full text]
[PDF]
- Technical Briefs
Use of Denaturing HPLC for Detection of Mutations in the BCR-ABL Kinase Domain in Patients Resistant to Imatinib
- Julie A.E. Irving, Stephen O’Brien, Anne L. Lennard, Lynne Minto, Feng Lin, and Andrew G. Hall
Clin. Chem. 2004; 50: 1233-1237.
[Extract]
[Full text]
[PDF]
- Technical Briefs
N-Acetyltransferase 2 Genotyping: An Accurate and Feasible Approach for Simultaneous Detection of the Most Common NAT2 Alleles
- Richard Brans, Danute Laizane, Annika Khan, and Brunhilde Blömeke
Clin. Chem. 2004; 50: 1264-1266.
[Extract]
[Full text]
[PDF]
- Technical Briefs
Mass Spectrometric Identification of Ethyl Sulfate as an Ethanol Metabolite in Humans
- Anders Helander and Olof Beck
Clin. Chem. 2004; 50: 936-937.
[Extract]
[Full text]
[PDF]
- Drug Monitoring and Toxicology
Analytic Performance of Immunoassays for Drugs of Abuse Below Established Cutoff Values
- Veronica I. Luzzi, Al N. Saunders, John W. Koenig, John Turk, Stanley F. Lo, Uttam C. Garg, and Dennis J. Dietzen
Clin. Chem. 2004; 50: 717-722.
[Abstract]
[Full text]
[PDF]
- Drug Monitoring and Toxicology
Detection of Hemoglobin-Based Oxygen Carriers in Human Serum for Doping Analysis: Confirmation by Size-Exclusion HPLC
- Emmanuelle Varlet-Marie, Michael Ashenden, Françoise Lasne, Marie-Therese Sicart, Benedicte Marion, Jacques de Ceaurriz, and Michel Audran
Clin. Chem. 2004; 50: 723-731.
[Abstract]
[Full text]
[PDF]
- Letters to the Editor
Which Types of Alcohol-Use Disorder Will Asialotransferrin Detect?
- Raymund Schwan, L. Malet, M.N. Loiseaux, and P.M. Llorca
Clin. Chem. 2004; 50: 782.
[Extract]
[Full text]
[PDF]
- Editorials
Biosynthesis of Endogenous Cardiac Glycosides by Mammalian Adrenocortical Cells: Three Steps Forward
- John M. Hamlyn
Clin. Chem. 2004; 50: 469-470.
[Extract]
[Full text]
[PDF]
|
|
